Spire Healthcare says trading in line, reiterates guidance

FTSE 250 hospital group Spire Healthcare said on Friday that trading from 1 January to 25 May has been in line with expectations, as it reiterated its 2017 guidance.

The company said the recovery plan for Spire St Anthony's hospital remains on track, with a return to profit expected in the 2017 financial year.

Meanwhile, its new Manchester hospital opened for business in January and is performing "satisfactorily", while Spire's new Nottingham hospital opened for business on schedule at the end of April.

"All other development projects set out in our full year results presentation are on budget and on schedule," it said.

Spire said at its full-year results in March that it expects revenue growth of between 3% and 5%, EBITDA in line with 2016 at £162m and capital expenditure of between £140m and £165m.